Cargando…

Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review

OBJECTIVE: The identification of methodology for modelling cardiovascular disease (CVD) risk using longitudinal data and risk factor trajectories. METHODS: We screened MEDLINE-Ovid from inception until 3 June 2020. MeSH and text search terms covered three areas: data type, modelling type and disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevens, David, Lane, Deirdre A., Harrison, Stephanie L., Lip, Gregory Y. H., Kolamunnage-Dona, Ruwanthi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684210/ https://www.ncbi.nlm.nih.gov/pubmed/34922465 http://dx.doi.org/10.1186/s12874-021-01472-x

Ejemplares similares

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Bayesian joint modelling of longitudinal and time to event data: a methodological review
por: Alsefri, Maha, et al.
Publicado: (2020)

Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials
por: Powney, Matthew, et al.
Publicado: (2013)

Adjusting for informative missing outcome data in clinical trials with longitudinal study designs
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2013)

Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2016)

Correction to: joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2018)

A review of the handling of missing longitudinal outcome data in clinical trials
por: Powney, Matthew, et al.
Publicado: (2014)

Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2016)

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2016)

Investigation of 2‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2017)

Investigation of one‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2018)

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2017)

Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues
por: Hickey, Graeme L., et al.
Publicado: (2016)

joineRML: a joint model and software package for time-to-event and multivariate longitudinal outcomes
por: Hickey, Graeme L., et al.
Publicado: (2018)

Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1
por: Antoniou, Miranta, et al.
Publicado: (2018)

Evaluating statistical characteristics of biomarker-guided trial designs
por: Antoniou, Miranta, et al.
Publicado: (2015)

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19
por: Antoniou, Miranta, et al.
Publicado: (2018)

Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size
por: Antoniou, Miranta, et al.
Publicado: (2017)

Time-dependent ROC curve analysis in medical research: current methods and applications
por: Kamarudin, Adina Najwa, et al.
Publicado: (2017)

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Spatial Linear Mixed Effects Modelling for OCT Images: SLME Model †
por: Zhu, Wenyue, et al.
Publicado: (2020)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Spatial and spatio-temporal statistical analyses of retinal images: a review of methods and applications
por: Zhu, Wenyue, et al.
Publicado: (2020)

Assessment and clinical course of hypocalcemia in critical illness
por: Steele, Tom, et al.
Publicado: (2013)

The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke
por: Harrison, Stephanie L, et al.
Publicado: (2022)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Adjusting for treatment changes in epilepsy: causal analysis of randomised controlled trial survival outcomes in the presence of departure from randomised treatment
por: Dodd, Susanna, et al.
Publicado: (2013)

Assessing the potential for outcome reporting bias in a review: a tutorial
por: Dwan, Kerry, et al.
Publicado: (2010)

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
por: Kovanda, Laura L., et al.
Publicado: (2017)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews
por: Harrison, Stephanie L, et al.
Publicado: (2021)

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
por: Lane, Deirdre A., et al.
Publicado: (2018)

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
por: Proietti, Marco, et al.
Publicado: (2016)

Cardiovascular Disease Risk Models and Longitudinal Changes in Cognition: A Systematic Review
por: Harrison, Stephanie L., et al.
Publicado: (2014)

A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC)
por: Owens, Lynn, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r8bgi7ac3usfrga2in933c1grc